AVITA Medical (RCEL) reported Q1 loss late Thursday of $0.35 per diluted share, narrowing from a loss of $0.53 a year earlier.

Analyst polled by FactSet expected a loss of $0.29.

Total revenue for the quarter ended March 31 rose to $19.3 million from $18.3 million a year earlier.

Analysts surveyed by FactSet expected $18.3 million.

For full-year 2026, the company reaffirmed its revenue guidance of $80 million to $85 million. Analysts expect $82.4 million.